Journal
OPEN BIOLOGY
Volume 6, Issue 8, Pages -Publisher
ROYAL SOC
DOI: 10.1098/rsob.160134
Keywords
apoptosis; spindle checkpoint; paclitaxel; taxol; WEHI-539
Categories
Funding
- Cancer Research UK
- University of Manchester
- Wellcome Trust
- Medical Research Council [MR/L006839/1]
- Cancer Research UK [19842, 11913] Funding Source: researchfish
- Medical Research Council [MR/L006839/1] Funding Source: researchfish
- MRC [MR/L006839/1] Funding Source: UKRI
Ask authors/readers for more resources
Cell fate in response to an aberrant mitosis is governed by two competing networks: the spindle assembly checkpoint (SAC) and the intrinsic apoptosis pathway. The mechanistic interplay between these two networks is obscured by functional redundancy and the ability of cells to die either in mitosis or in the subsequent interphase. By coupling time-lapse microscopy with selective pharmacological agents, we systematically probe pro-survival Bcl-xL in response to various mitotic perturbations. Concentration matrices show that BH3-mimetic-mediated inhibition of Bcl-xL synergises with perturbations that induce an SAC-mediated mitotic block, including drugs that dampen microtubule dynamics, and inhibitors targeting kinesins and kinases required for spindle assembly. By contrast, Bcl-xL inhibition does not synergize with drugs which drive cells through an aberrant mitosis by overriding the SAC. This differential effect, which is explained by compensatory Mcl-1 function, provides opportunities for patient stratification and combination treatments in the context of cancer chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available